KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Cash & Current Investments (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Cash & Current Investments for 17 consecutive years, with $8.9 billion as the latest value for Q4 2025.

  • Quarterly Cash & Current Investments rose 12.2% to $8.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $8.9 billion through Dec 2025, up 12.2% year-over-year, with the annual reading at $8.9 billion for FY2025, 12.2% up from the prior year.
  • Cash & Current Investments hit $8.9 billion in Q4 2025 for Abbott Laboratories, up from $7.7 billion in the prior quarter.
  • In the past five years, Cash & Current Investments ranged from a high of $10.2 billion in Q4 2021 to a low of $6.7 billion in Q1 2024.
  • Historically, Cash & Current Investments has averaged $8.4 billion across 5 years, with a median of $8.2 billion in 2022.
  • Biggest five-year swings in Cash & Current Investments: skyrocketed 128.24% in 2021 and later crashed 30.22% in 2024.
  • Year by year, Cash & Current Investments stood at $10.2 billion in 2021, then dropped by 0.77% to $10.2 billion in 2022, then dropped by 28.43% to $7.3 billion in 2023, then rose by 9.45% to $8.0 billion in 2024, then grew by 12.2% to $8.9 billion in 2025.
  • Business Quant data shows Cash & Current Investments for ABT at $8.9 billion in Q4 2025, $7.7 billion in Q3 2025, and $7.3 billion in Q2 2025.